Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide
Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<...
Ausführliche Beschreibung
Autor*in: |
Ruchika Ojha [verfasserIn] Peter C. Junk [verfasserIn] Alan M. Bond [verfasserIn] Glen B. Deacon [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2023 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Molecules - MDPI AG, 2003, 28(2023), 17, p 6402 |
---|---|
Übergeordnetes Werk: |
volume:28 ; year:2023 ; number:17, p 6402 |
Links: |
---|
DOI / URN: |
10.3390/molecules28176402 |
---|
Katalog-ID: |
DOAJ09349789X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ09349789X | ||
003 | DE-627 | ||
005 | 20240413011918.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/molecules28176402 |2 doi | |
035 | |a (DE-627)DOAJ09349789X | ||
035 | |a (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QD241-441 | |
100 | 0 | |a Ruchika Ojha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. | ||
650 | 4 | |a platinum anticancer agents | |
650 | 4 | |a platinum(II) complexes | |
650 | 4 | |a platinum(IV) complexes | |
650 | 4 | |a hydrogen peroxide oxidation of platinum(II) complexes | |
653 | 0 | |a Organic chemistry | |
700 | 0 | |a Peter C. Junk |e verfasserin |4 aut | |
700 | 0 | |a Alan M. Bond |e verfasserin |4 aut | |
700 | 0 | |a Glen B. Deacon |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Molecules |d MDPI AG, 2003 |g 28(2023), 17, p 6402 |w (DE-627)311313132 |w (DE-600)2008644-1 |x 14203049 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2023 |g number:17, p 6402 |
856 | 4 | 0 | |u https://doi.org/10.3390/molecules28176402 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/1420-3049/28/17/6402 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1420-3049 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 28 |j 2023 |e 17, p 6402 |
author_variant |
r o ro p c j pcj a m b amb g b d gbd |
---|---|
matchkey_str |
article:14203049:2023----::xdtooteltnminiacrgnpiirsbsbsbsbcsbsbhu2untu2ucptp |
hierarchy_sort_str |
2023 |
callnumber-subject-code |
QD |
publishDate |
2023 |
allfields |
10.3390/molecules28176402 doi (DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 DE-627 ger DE-627 rakwb eng QD241-441 Ruchika Ojha verfasserin aut Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry Peter C. Junk verfasserin aut Alan M. Bond verfasserin aut Glen B. Deacon verfasserin aut In Molecules MDPI AG, 2003 28(2023), 17, p 6402 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:28 year:2023 number:17, p 6402 https://doi.org/10.3390/molecules28176402 kostenfrei https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 kostenfrei https://www.mdpi.com/1420-3049/28/17/6402 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 28 2023 17, p 6402 |
spelling |
10.3390/molecules28176402 doi (DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 DE-627 ger DE-627 rakwb eng QD241-441 Ruchika Ojha verfasserin aut Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry Peter C. Junk verfasserin aut Alan M. Bond verfasserin aut Glen B. Deacon verfasserin aut In Molecules MDPI AG, 2003 28(2023), 17, p 6402 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:28 year:2023 number:17, p 6402 https://doi.org/10.3390/molecules28176402 kostenfrei https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 kostenfrei https://www.mdpi.com/1420-3049/28/17/6402 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 28 2023 17, p 6402 |
allfields_unstemmed |
10.3390/molecules28176402 doi (DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 DE-627 ger DE-627 rakwb eng QD241-441 Ruchika Ojha verfasserin aut Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry Peter C. Junk verfasserin aut Alan M. Bond verfasserin aut Glen B. Deacon verfasserin aut In Molecules MDPI AG, 2003 28(2023), 17, p 6402 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:28 year:2023 number:17, p 6402 https://doi.org/10.3390/molecules28176402 kostenfrei https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 kostenfrei https://www.mdpi.com/1420-3049/28/17/6402 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 28 2023 17, p 6402 |
allfieldsGer |
10.3390/molecules28176402 doi (DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 DE-627 ger DE-627 rakwb eng QD241-441 Ruchika Ojha verfasserin aut Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry Peter C. Junk verfasserin aut Alan M. Bond verfasserin aut Glen B. Deacon verfasserin aut In Molecules MDPI AG, 2003 28(2023), 17, p 6402 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:28 year:2023 number:17, p 6402 https://doi.org/10.3390/molecules28176402 kostenfrei https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 kostenfrei https://www.mdpi.com/1420-3049/28/17/6402 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 28 2023 17, p 6402 |
allfieldsSound |
10.3390/molecules28176402 doi (DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 DE-627 ger DE-627 rakwb eng QD241-441 Ruchika Ojha verfasserin aut Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry Peter C. Junk verfasserin aut Alan M. Bond verfasserin aut Glen B. Deacon verfasserin aut In Molecules MDPI AG, 2003 28(2023), 17, p 6402 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:28 year:2023 number:17, p 6402 https://doi.org/10.3390/molecules28176402 kostenfrei https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 kostenfrei https://www.mdpi.com/1420-3049/28/17/6402 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 28 2023 17, p 6402 |
language |
English |
source |
In Molecules 28(2023), 17, p 6402 volume:28 year:2023 number:17, p 6402 |
sourceStr |
In Molecules 28(2023), 17, p 6402 volume:28 year:2023 number:17, p 6402 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes Organic chemistry |
isfreeaccess_bool |
true |
container_title |
Molecules |
authorswithroles_txt_mv |
Ruchika Ojha @@aut@@ Peter C. Junk @@aut@@ Alan M. Bond @@aut@@ Glen B. Deacon @@aut@@ |
publishDateDaySort_date |
2023-01-01T00:00:00Z |
hierarchy_top_id |
311313132 |
id |
DOAJ09349789X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09349789X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413011918.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/molecules28176402</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09349789X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJee678a2ce5814275996c87dc288a3dd9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD241-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ruchika Ojha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum anticancer agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum(II) complexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum(IV) complexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hydrogen peroxide oxidation of platinum(II) complexes</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Organic chemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Peter C. Junk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alan M. Bond</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Glen B. Deacon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Molecules</subfield><subfield code="d">MDPI AG, 2003</subfield><subfield code="g">28(2023), 17, p 6402</subfield><subfield code="w">(DE-627)311313132</subfield><subfield code="w">(DE-600)2008644-1</subfield><subfield code="x">14203049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:28</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:17, p 6402</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/molecules28176402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1420-3049/28/17/6402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1420-3049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">28</subfield><subfield code="j">2023</subfield><subfield code="e">17, p 6402</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
Ruchika Ojha |
spellingShingle |
Ruchika Ojha misc QD241-441 misc platinum anticancer agents misc platinum(II) complexes misc platinum(IV) complexes misc hydrogen peroxide oxidation of platinum(II) complexes misc Organic chemistry Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
authorStr |
Ruchika Ojha |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)311313132 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QD241-441 |
illustrated |
Not Illustrated |
issn |
14203049 |
topic_title |
QD241-441 Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide platinum anticancer agents platinum(II) complexes platinum(IV) complexes hydrogen peroxide oxidation of platinum(II) complexes |
topic |
misc QD241-441 misc platinum anticancer agents misc platinum(II) complexes misc platinum(IV) complexes misc hydrogen peroxide oxidation of platinum(II) complexes misc Organic chemistry |
topic_unstemmed |
misc QD241-441 misc platinum anticancer agents misc platinum(II) complexes misc platinum(IV) complexes misc hydrogen peroxide oxidation of platinum(II) complexes misc Organic chemistry |
topic_browse |
misc QD241-441 misc platinum anticancer agents misc platinum(II) complexes misc platinum(IV) complexes misc hydrogen peroxide oxidation of platinum(II) complexes misc Organic chemistry |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Molecules |
hierarchy_parent_id |
311313132 |
hierarchy_top_title |
Molecules |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)311313132 (DE-600)2008644-1 |
title |
Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
ctrlnum |
(DE-627)DOAJ09349789X (DE-599)DOAJee678a2ce5814275996c87dc288a3dd9 |
title_full |
Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
author_sort |
Ruchika Ojha |
journal |
Molecules |
journalStr |
Molecules |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2023 |
contenttype_str_mv |
txt |
author_browse |
Ruchika Ojha Peter C. Junk Alan M. Bond Glen B. Deacon |
container_volume |
28 |
class |
QD241-441 |
format_se |
Elektronische Aufsätze |
author-letter |
Ruchika Ojha |
doi_str_mv |
10.3390/molecules28176402 |
author2-role |
verfasserin |
title_sort |
oxidation of the platinum(ii) anticancer agent [pt{(<i<p</i<-brc<sub<6</sub<f<sub<4</sub<)nch<sub<2</sub<ch<sub<2</sub<net<sub<2</sub<}cl(py)] to platinum(iv) complexes by hydrogen peroxide |
callnumber |
QD241-441 |
title_auth |
Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
abstract |
Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. |
abstractGer |
Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. |
abstract_unstemmed |
Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
17, p 6402 |
title_short |
Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide |
url |
https://doi.org/10.3390/molecules28176402 https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9 https://www.mdpi.com/1420-3049/28/17/6402 https://doaj.org/toc/1420-3049 |
remote_bool |
true |
author2 |
Peter C. Junk Alan M. Bond Glen B. Deacon |
author2Str |
Peter C. Junk Alan M. Bond Glen B. Deacon |
ppnlink |
311313132 |
callnumber-subject |
QD - Chemistry |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/molecules28176402 |
callnumber-a |
QD241-441 |
up_date |
2024-07-03T17:40:40.777Z |
_version_ |
1803580542322475008 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09349789X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413011918.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/molecules28176402</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09349789X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJee678a2ce5814275996c87dc288a3dd9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD241-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ruchika Ojha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pt<sup<IV</sup< coordination complexes are of interest as prodrugs of Pt<sup<II</sup< anticancer agents, as they can avoid deactivation pathways owing to their inert nature. Here, we report the oxidation of the antitumor agent [Pt<sup<II</sup<(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(py)], <b<1</b< (py = pyridine) to dihydroxidoplatinum(IV) solvate complexes [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].H<sub<2</sub<O, <b<2·H<sub<2</sub<O</b< with hydrogen peroxide (H<sub<2</sub<O<sub<2</sub<) at room temperature. To optimize the yield, <b<1</b< was oxidized in the presence of added lithium chloride with H<sub<2</sub<O<sub<2</sub< in a 1:2 ratio of Pt: H<sub<2</sub<O<sub<2,</sub< in CH<sub<2</sub<Cl<sub<2</sub< producing complex <b<2·H<sub<2</sub<O</b< in higher yields in both gold and red forms. Despite the color difference, red and yellow <b<2·H<sub<2</sub<O</b< have the same structure as determined by single-crystal and X-ray powder diffraction, namely, an octahedral ligand array with a chelating organoamide, pyridine and chloride ligands in the equatorial plane, and axial hydroxido ligands. When tetrabutylammonium chloride was used as a chloride source, in CH<sub<2</sub<Cl<sub<2</sub<, another solvate, [Pt<sup<IV</sup<{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH<sub<2</sub<CH<sub<2</sub<NEt<sub<2</sub<}Cl(OH)<sub<2</sub<(py)].0.5CH<sub<2</sub<Cl<sub<2,</sub<<b<3·0.5CH<sub<2</sub<Cl<sub<2</sub<</b<, was obtained. These Pt<sup<IV</sup< compounds show reductive dehydration into Pt<sup<II</sup< [Pt{(<i<p</i<-BrC<sub<6</sub<F<sub<4</sub<)NCH=CHNEt<sub<2</sub<}Cl(py)], <b<1H</b< over time in the solid state, as determined by X-ray powder diffraction, and in solution, as determined by <sup<1</sup<H and <sup<19</sup<F NMR spectroscopy and mass spectrometry. <b<1H</b< contains an oxidized coordinating ligand and was previously obtained by oxidation of <b<1</b< under more vigorous conditions. Experimental data suggest that oxidation of the ligand is favored in the presence of excess H<sub<2</sub<O<sub<2</sub< and elevated temperatures. In contrast, a smaller amount (1Pt:2H<sub<2</sub<O<sub<2</sub<) of H<sub<2</sub<O<sub<2</sub< at room temperature favors the oxidation of the metal and yields platinum(IV) complexes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum anticancer agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum(II) complexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platinum(IV) complexes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hydrogen peroxide oxidation of platinum(II) complexes</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Organic chemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Peter C. Junk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alan M. Bond</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Glen B. Deacon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Molecules</subfield><subfield code="d">MDPI AG, 2003</subfield><subfield code="g">28(2023), 17, p 6402</subfield><subfield code="w">(DE-627)311313132</subfield><subfield code="w">(DE-600)2008644-1</subfield><subfield code="x">14203049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:28</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:17, p 6402</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/molecules28176402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ee678a2ce5814275996c87dc288a3dd9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1420-3049/28/17/6402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1420-3049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">28</subfield><subfield code="j">2023</subfield><subfield code="e">17, p 6402</subfield></datafield></record></collection>
|
score |
7.3993664 |